Innovations in Immunoassay Techniques Used to Analyze Biopharmaceutical Drugs and Biomarkers at LGC

Watch this video to learn about the immunoassay techniques used to analyze samples from preclinical and clinical trials to screen for biopharmaceutical drugs, immunogenicity and analyze biomarkers. Robin Longdin, Sector Manager of the Biologics department within Drug Development Services at LGC, discusses how particular technologies have enabled them to analyze low abundant samples and achieve better results than conventional immunoassay techniques.